Part 3
Tessa Rowan was still there, crossing Lakeshore’s administrative corridor with a blue canvas tote crushed against her ribs. Mara had spent forty minutes in a public waiting area, Ranger tucked beneath her chair, until the young data coordinator appeared. Tessa saw her, stopped, and glanced toward the security camera above the elevator.
“Mrs. Whitaker, I can’t talk here.”
“Then choose somewhere you can.”
Tessa led her into an empty employee break room and left the door ajar. She looked barely thirty, though exhaustion had drawn older shadows beneath her eyes. “I’m sorry about Ben. I wanted to come to the funeral, but Dr. Vale said contact with trial families was restricted.”
“Ben wrote your name.” Mara kept her voice low. “He said you wanted to tell him something.”
The tote shifted as Tessa gripped it. Ranger stood and sampled the air. He moved one step toward the bag, then sat. Tessa recoiled.
“What is he doing?”
“Recognizing an odor, probably from something Ben used in training. That doesn’t tell me what’s in your bag. You do.”
For several seconds, the only sound was the vending machine compressor. Tessa shut the door. From the tote she removed a sealed N-17 transport pouch and four flash drives wrapped in a rubber band.
“The pouch carried returned vials,” she said. “It’s empty, but the lining may still smell. I kept the drives because they started changing the database after Ben died.”
Mara did not reach for them. “Call a lawyer before you give me anything.”
Tessa stared as if kindness were a trick. Then words came in a rush. She had joined Lakeshore believing the study offered compassionate access to children with few options. Randomized placebo-controlled trials could be ethical when families understood the design and clinical safeguards protected participants. N-17 was not operating that way. Recruitment staff promised active medication. Managers then moved selected children into an undisclosed control cohort and altered signed consent pages in the archive. Some families were charged program fees tied to drug administration they had not received.
“I noticed the biomarker patterns didn’t match the reported assignments,” Tessa said. “Dr. Vale told me to normalize outliers. When I refused, he took over my credentials for a week. The clean reports went to the monitor. The originals stayed on the internal server.”
“And Everett Shaw?” Mara asked, recognizing the pharmaceutical executive Ben had named only as Mr. Shaw.
Tessa’s mouth tightened. “His office sent enrollment targets and lists of families least likely to challenge billing. I copied those messages. I don’t know what he personally approved beyond what bears his account. I won’t claim more.”
The precision made Mara trust her more than tears would have.
“Did the allocation cause Ben’s death?”
“I can’t tell you that. No one can promise the study drug would have helped him. But you were denied the choice you were told you had, and his worsening symptoms were stripped from the safety report. That is what I know.”
It was both less and worse than the answer Mara had imagined. Ben had not been robbed of a guaranteed cure; there had never been one. He had been robbed of honest consent, appropriate monitoring, and adults willing to record what happened to him.
Tessa covered her face. “He asked me why his infusion bag code never matched Tommy’s. I told him codes changed by site. He knew I was lying.”
Ranger lowered his head onto her knee. Tessa froze, then rested two fingers between his ears.
“You need independent counsel,” Mara said. “My attorney represents my family, not you. She can refer you to someone who handles whistleblowers. Until then, keep the drives. Don’t access anything you aren’t authorized to access, and don’t alter a file.”
Tessa looked up. “Why aren’t you yelling at me?”
“Because my son is buried, and yelling won’t protect the children still enrolled.” Mara heard the hardness in her own voice. “But helping now does not erase what you ignored then. You’ll have to live inside both truths.”
Tessa nodded once. “Enrollment resumes Monday. Six new children are scheduled.”
That afternoon, attorney Denise Holloway arranged separate counsel for Tessa and brought in a forensic consultant. In a conference room above a tire shop, they inventoried each drive on video. Tessa retained the originals; verified copies went into encrypted storage under her lawyer’s control. Mara surrendered the vial’s sealed container to an accredited laboratory through a documented transfer. A chemist explained that analysis might identify the formulation, contamination, or neither. Ranger’s behavior would not be part of the chemical conclusion.
For three hours, Tessa described altered allocation lists, missing adverse-event pages, and the difference between a legitimate control group and one concealed from desperate parents. Denise listened without drama and circled what could be supported. “We petition the state medical board and federal trial regulators for emergency review,” she said. “If active enrollment continues, they can impose interim protections while facts are investigated. They cannot convict anybody at a hearing, and neither can a newspaper.”
“A newspaper?” Daniel asked.
“Public scrutiny may prevent records from quietly disappearing. It also makes every mistake we make more expensive.”
When the meeting ended, Daniel had to return to base. He wanted Mara to wait until he could drive her, but she refused to be treated as fragile. Ranger climbed into the back seat of her aging blue Subaru, and she took the county road toward home.
The black SUV appeared seven miles later. It came up fast, hung inches from her bumper, and matched each change in speed. Mara called 911 on speaker and gave the dispatcher her route. She could not see a plate through the dark cover. The road narrowed beside the ravine. In her side mirror, the black grille swelled and then vanished as the SUV occupied the space beside her door. Its tires crossed the center line.
Ranger barked once behind her. Mara did not need him to interpret two tons of metal crossing the center line. Convoy training returned as a sequence rather than courage: hands low, eyes where she needed to go, no abrupt turn toward the drop. She eased right enough to create space, then braked hard before the SUV completed its move. It swept past. Its rear tires broke loose, corrected, and disappeared around the curve.
Mara stopped in a church parking lot and waited for the deputy with both doors locked. Her knees began shaking only after she had read the dispatcher the last landmark. Daniel arrived while the deputy photographed a scrape of black paint on her mirror.
“Could have been road rage,” the deputy said. “Could have been targeted. Without a plate or driver identification, we don’t assign a motive.”
Mara agreed. Suspicion was not evidence. Still, only a handful of people knew where she had spent the afternoon, and someone had met her on the first isolated stretch after she left.
Then Tessa called from her attorney’s office. Lakeshore had disabled her credentials, and all six Monday appointments still showed as confirmed.
“They know,” she said. “And they’re going ahead anyway.”
To read the rest of the story – CLICK the NEXT button 👇👇👇